Altasciences completed the acquisition of Calvert Laboratories for $40m.

Altasciences, a forward-thinking, mid-size contract research organization, completed the acquisition of Calvert Laboratories, a contract research organization, for $40m. “This acquisition will increase small molecule expertise as well as add efficacy pharmacology, ophthalmology, and carcinogenicity study capabilities, to Altasciences’ current preclinical offering. Furthermore, it expands Altasciences’ presence on the East Coast, and the site is conveniently located in close proximity to our CDMO facility,” Steve Mason, Altasciences Co-Chief Operating Officer.